TY  - JOUR
AU  - Gonzalez-Serna, A
AU  - Genebat, M
AU  - De-Luna-Romero, M
AU  - Tarancon-Diez, L
AU  - Dominguez-Molina, B
AU  - Pacheco, Y M
AU  - Muñoz-Fernandez, M A
AU  - Leal, M
AU  - Ruiz-Mateos, E
PY  - 2016
DO  - 10.1128/AAC.01326-16
UR  - http://hdl.handle.net/10668/10329
T2  - Antimicrobial agents and chemotherapy
AB  - TROCAI is a phenotypic tropism test developed using the virological response to a short-term exposure to maraviroc monotherapy (Maraviroc Clinical Test [MCT]). It was found that with TROCAI, a cutoff of <0.5% of dual/mixed viruses was needed to...
LA  - en
PB  - American Society for Microbiology
KW  - HIV tropism
KW  - Maraviroc
KW  - Monotherapy
KW  - Phenotypic test
KW  - Virological response
KW  - HIV drug resistance
KW  - Diagnostic accuracy
KW  - Cyclohexanes
KW  - HIV
KW  - HIV Fusion Inhibitors
KW  - Humans
KW  - Inhibitory Concentration 50
KW  - Maraviroc
KW  - Triazoles
KW  - Viral Tropism
KW  - Virology
TI  - Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure.
TY  - research article
VL  - 60
ER  -